233 related articles for article (PubMed ID: 25227914)
1. Dominant mutations in ORAI1 cause tubular aggregate myopathy with hypocalcemia via constitutive activation of store-operated Ca²⁺ channels.
Endo Y; Noguchi S; Hara Y; Hayashi YK; Motomura K; Miyatake S; Murakami N; Tanaka S; Yamashita S; Kizu R; Bamba M; Goto Y; Matsumoto N; Nonaka I; Nishino I
Hum Mol Genet; 2015 Feb; 24(3):637-48. PubMed ID: 25227914
[TBL] [Abstract][Full Text] [Related]
2. ORAI1 channel gating and selectivity is differentially altered by natural mutations in the first or third transmembrane domain.
Bulla M; Gyimesi G; Kim JH; Bhardwaj R; Hediger MA; Frieden M; Demaurex N
J Physiol; 2019 Jan; 597(2):561-582. PubMed ID: 30382595
[TBL] [Abstract][Full Text] [Related]
3. ORAI1 Mutations with Distinct Channel Gating Defects in Tubular Aggregate Myopathy.
Böhm J; Bulla M; Urquhart JE; Malfatti E; Williams SG; O'Sullivan J; Szlauer A; Koch C; Baranello G; Mora M; Ripolone M; Violano R; Moggio M; Kingston H; Dawson T; DeGoede CG; Nixon J; Boland A; Deleuze JF; Romero N; Newman WG; Demaurex N; Laporte J
Hum Mutat; 2017 Apr; 38(4):426-438. PubMed ID: 28058752
[TBL] [Abstract][Full Text] [Related]
4. Activating mutations in STIM1 and ORAI1 cause overlapping syndromes of tubular myopathy and congenital miosis.
Nesin V; Wiley G; Kousi M; Ong EC; Lehmann T; Nicholl DJ; Suri M; Shahrizaila N; Katsanis N; Gaffney PM; Wierenga KJ; Tsiokas L
Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4197-202. PubMed ID: 24591628
[TBL] [Abstract][Full Text] [Related]
5. Diseases caused by mutations in ORAI1 and STIM1.
Lacruz RS; Feske S
Ann N Y Acad Sci; 2015 Nov; 1356(1):45-79. PubMed ID: 26469693
[TBL] [Abstract][Full Text] [Related]
6. Calcium Dyshomeostasis in Tubular Aggregate Myopathy.
Lee JM; Noguchi S
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27879676
[TBL] [Abstract][Full Text] [Related]
7. Constitutive activation of the calcium sensor STIM1 causes tubular-aggregate myopathy.
Böhm J; Chevessier F; Maues De Paula A; Koch C; Attarian S; Feger C; Hantaï D; Laforêt P; Ghorab K; Vallat JM; Fardeau M; Figarella-Branger D; Pouget J; Romero NB; Koch M; Ebel C; Levy N; Krahn M; Eymard B; Bartoli M; Laporte J
Am J Hum Genet; 2013 Feb; 92(2):271-8. PubMed ID: 23332920
[TBL] [Abstract][Full Text] [Related]
8. A novel gain-of-function mutation in ORAI1 causes late-onset tubular aggregate myopathy and congenital miosis.
Garibaldi M; Fattori F; Riva B; Labasse C; Brochier G; Ottaviani P; Sacconi S; Vizzaccaro E; Laschena F; Romero NB; Genazzani A; Bertini E; Antonini G
Clin Genet; 2017 May; 91(5):780-786. PubMed ID: 27882542
[TBL] [Abstract][Full Text] [Related]
9. Calcium entry units (CEUs): perspectives in skeletal muscle function and disease.
Protasi F; Pietrangelo L; Boncompagni S
J Muscle Res Cell Motil; 2021 Jun; 42(2):233-249. PubMed ID: 32812118
[TBL] [Abstract][Full Text] [Related]
10. Tubular aggregate myopathy and Stormorken syndrome: Mutation spectrum and genotype/phenotype correlation.
Morin G; Biancalana V; Echaniz-Laguna A; Noury JB; Lornage X; Moggio M; Ripolone M; Violano R; Marcorelles P; Maréchal D; Renaud F; Maurage CA; Tard C; Cuisset JM; Laporte J; Böhm J
Hum Mutat; 2020 Jan; 41(1):17-37. PubMed ID: 31448844
[TBL] [Abstract][Full Text] [Related]
11. CRAC channels and disease - From human CRAC channelopathies and animal models to novel drugs.
Feske S
Cell Calcium; 2019 Jun; 80():112-116. PubMed ID: 31009822
[TBL] [Abstract][Full Text] [Related]
12. Role of STIM1/ORAI1-mediated store-operated Ca
Michelucci A; García-Castañeda M; Boncompagni S; Dirksen RT
Cell Calcium; 2018 Dec; 76():101-115. PubMed ID: 30414508
[TBL] [Abstract][Full Text] [Related]
13. Hypertrophy in skeletal myotubes induced by junctophilin-2 mutant, Y141H, involves an increase in store-operated Ca2+ entry via Orai1.
Woo JS; Cho CH; Lee KJ; Kim DH; Ma J; Lee EH
J Biol Chem; 2012 Apr; 287(18):14336-48. PubMed ID: 22389502
[TBL] [Abstract][Full Text] [Related]
14. The TAM-associated STIM1
Kim JH; Carreras-Sureda A; Didier M; Henry C; Frieden M; Demaurex N
Cell Calcium; 2022 Jul; 105():102615. PubMed ID: 35792400
[TBL] [Abstract][Full Text] [Related]
15. STIM1 and ORAI1 mutations leading to tubular aggregate myopathies are sensitive to the Store-operated Ca
Riva B; Pessolano E; Quaglia E; Cordero-Sanchez C; Bhela IP; Topf A; Serafini M; Cox D; Harris E; Garibaldi M; Barresi R; Pirali T; Genazzani AA
Cell Calcium; 2022 Jul; 105():102605. PubMed ID: 35636153
[TBL] [Abstract][Full Text] [Related]
16. STIM1-Orai1 interactions and Orai1 conformational changes revealed by live-cell FRET microscopy.
Navarro-Borelly L; Somasundaram A; Yamashita M; Ren D; Miller RJ; Prakriya M
J Physiol; 2008 Nov; 586(22):5383-401. PubMed ID: 18832420
[TBL] [Abstract][Full Text] [Related]
17. Clinical, histological and genetic characterisation of patients with tubular aggregate myopathy caused by mutations in STIM1.
Böhm J; Chevessier F; Koch C; Peche GA; Mora M; Morandi L; Pasanisi B; Moroni I; Tasca G; Fattori F; Ricci E; Pénisson-Besnier I; Nadaj-Pakleza A; Fardeau M; Joshi PR; Deschauer M; Romero NB; Eymard B; Laporte J
J Med Genet; 2014 Dec; 51(12):824-33. PubMed ID: 25326555
[TBL] [Abstract][Full Text] [Related]
18. Gain-of-function mutations in STIM1 and ORAI1 causing tubular aggregate myopathy and Stormorken syndrome.
Böhm J; Laporte J
Cell Calcium; 2018 Dec; 76():1-9. PubMed ID: 30243034
[TBL] [Abstract][Full Text] [Related]
19. A dominant STIM1 mutation causes Stormorken syndrome.
Misceo D; Holmgren A; Louch WE; Holme PA; Mizobuchi M; Morales RJ; De Paula AM; Stray-Pedersen A; Lyle R; Dalhus B; Christensen G; Stormorken H; Tjønnfjord GE; Frengen E
Hum Mutat; 2014 May; 35(5):556-64. PubMed ID: 24619930
[TBL] [Abstract][Full Text] [Related]
20. Silencing of the Ca
Silva-Rojas R; Pérez-Guàrdia L; Lafabrie E; Moulaert D; Laporte J; Böhm J
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
